Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome
Lixiang Zhai(Hong Kong Baptist University), Hoi Leong Xavier Wong(Hong Kong Baptist University), Haitao Xiao(Shenzhen University), Lok Ting Lau(Hong Kong Baptist University), Yan Y. Lam(Rutgers, The State University of New Jersey), Chao Yang(Jiangxi University of Traditional Chinese Medicine), Ziwan Ning(Hong Kong Baptist University), Chengyuan Lin(Hong Kong Baptist University), Ling Zhao(Shanghai Jiao Tong University), Zhaoxiang Bian(Hong Kong Baptist University), Aiping Lü(Hong Kong Baptist University), Guojun Wu(Northwest University), Mengxue Gong(Shanghai Jiao Tong University), Liping Zhao(Lanzhou University), Jingyuan Luo(Hong Kong Baptist University), Lu Zhang(Xiamen University), Wei Jia(Sichuan University), Yijing Zhang(Xuzhou Medical College), Chunhua Huang(Hong Kong Baptist University), Chenhong Zhang(Linyi University), Johnson Yiu‐Nam Lau(Hong Kong Baptist University)
Cited by 104
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5k
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
Enterotypes in the landscape of gut microbial community composition
|Nature Microbiology|2017|1.2k
Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice
|The ISME Journal|2009|1k
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome
|Alzheimer s & Dementia|2018|690